Parties involved in hundreds of Xarelto lawsuits pending in the federal multidistrict litigation underway in the U.S. District Court, Eastern District of Louisiana, will soon have an opportunity to apprise the Court of medical and scientific matters likely to be relevant to plaintiffs’ claims. According to an Order issued on April 7th, the Court will convene a Science Day on June 11th at 9:00 a.m.

Science Days are typical in many large, complex product liability litigations, especially those involving medical products. During the Xarelto Science Day, attorneys for both plaintiffs and defendants will have an opportunity to make presentations to the Court in a non-adversarial manner. Issues that could be addressed might include information about the role of Xarelto in treating its approved indications, data on internal bleeding and other adverse events allegedly related to its use, and information about agents and methods some doctors may have used to reverse Xarelto bleeding.

Xarelto Injury Claims

The Eastern District of Louisiana is home to more than 300 Xarelto lawsuits filed on behalf of individuals who allegedly experienced uncontrollable bleeding, stroke, deep vein thrombosis, pulmonary embolism and other life-threatening side effects while using the blood thinner. The lawsuits accuse the drug’s manufacturers of failing to warn patients and doctors about these risks, especially the fact that there is no approved agent to reverse Xarelto bleeding. They also claim that marketing which positioned Xarelto as a superior alternative to warfarin was misleading, and point out that bleeding associated with this decades-old blood thinner can be stopped with vitamin K.

The Xarelto multidistrict litigation was established last December, after it became clear that thousands of lawsuits could ultimately be filed in federal courts on behalf of individuals allegedly injured by the drug. In the course of the litigation, all of the pending claims will go through coordinated pretrial proceedings, including discovery and motions practices. This will help to preserve the resources of the Court, parties and witnesses by avoiding duplicative discovery and inconsistent motions across the docket.

Contact a Xarelto Lawyer Today

The Xarelto lawyers at Bernstein Liebhard LLP are already representing a number of plaintiffs who have filed claims in federal courts, and our legal staff continues to offer free case reviews to those who may have been harmed by this blood thinner. To learn more about filing your own Xarelto lawsuit, please contact our office today or a free, no-obligation legal review by calling 1-877-779-1414.

Published April 16, 2015 by